Prospect Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
542
+23
+4% +$23.5K 0.52% 37
2026
Q1
$477K Sell
519
-29
-5% -$29.4K 0.44% 39
2025
Q4
$589K Sell
548
-14
-2% -$13.4K 0.55% 37
2025
Q3
$429K Buy
562
+25
+5% +$18.6K 0.42% 39
2025
Q2
$419K Buy
537
+61
+13% +$47.4K 0.44% 37
2025
Q1
$393K Buy
476
+25
+6% +$20.8K 0.5% 38
2024
Q4
$348K Buy
+451
New +$373K 0.43% 39

Other funds holding LLY

Prospect Financial Group's LLY Position: Q2 2026 in Review

Prospect Financial Group increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $23.5K and bringing the position to 542 shares worth $650K. The position accounts for 0.52% of the portfolio, ranked #37.

Prospect Financial Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prospect Financial Group held 542 shares of Eli Lilly worth $650K as of Q2 2026.
  • Prospect Financial Group bought 23 Eli Lilly shares in Q2 2026, an estimated $23.5K.
  • Eli Lilly made up 0.52% of Prospect Financial Group's portfolio in Q2 2026, its #37 holding.
  • Prospect Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prospect Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.